Clinical Trial Update: EMPRA (EMPagliflozin and RAs in Kidney Disease) [Phase 2]

View source ↗

Summary

Phase 2 trial update of EMPRA studying empagliflozin in kidney disease; completed study in Type 2 diabetes with diabetic kidney disease and chronic kidney disea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Diabetic Kidney Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: Medical University of Vienna | Conditions: Diabetic Kidney Disease, Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED